Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer

A prospectively designed phase II study of non-small cell lung cancer stage IIIb and IV treated by gemcitabine and cisplatin was studied. The dosage of gemcitabine was lg/m2 weekly on day 1, 8 and 15. Cisplatin 100 mg/m2 was given on day 15 of each 28 day cycle. Twenty-eight patients were treated an...

全面介紹

Saved in:
書目詳細資料
Main Authors: Thongprasert S., Chewaskulyong B., Pothirat C.
格式: Article
語言:English
出版: 2014
在線閱讀:http://www.scopus.com/inward/record.url?eid=2-s2.0-0034849569&partnerID=40&md5=b3a2dbd695d69b2add961e0a458f9817
http://www.ncbi.nlm.nih.gov/pubmed/11460942
http://cmuir.cmu.ac.th/handle/6653943832/1983
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
機構: Chiang Mai University
語言: English